Biogen launches in Raleigh, cites delay in access to Alzheimer’s drugs, new technology
RESEARCH TRIANGLE PARK – Pharmaceutical giant Biogen is laying off its patient support staff in Raleigh, citing delays in patient access to its recently approved Alzheimer’s drug as well as progress in what it calls ” new technologies “.
The number of people affected has not been disclosed.
However, a person who alerted WRAL News to the cuts ahead of the company’s confirmation early Wednesday said “hundreds” of people had been affected.
Additionally, a report on TheLayoff.com, a website that tracks job cuts, said Biogen was cutting 200 jobs.
Biogen has invested heavily in expanding its drug research and production facilities at RTP, and the company continues to hire.
“Biogen has dozens of jobs in RTP and is still actively recruiting,” the spokesperson said.
The company has more than 1,400 employees in the Triangle, according to The Book of Lists published by the Triangle Business Journal.
News reports such as those from the medical industry news service Stat News indicated that Biogen was financially impacted by the deployment of Aduhelm, which was approved by the United States Food and Drug Administration in June. .
Biogen, which is based in Cambridge, Mass., May have to cut costs due to weak sales, Stat reported in September.
At a healthcare industry event, Biogen CEO Michel Vounatsos said there was “clearly too much confusion, misinformation and controversy surrounding our data and the approval process,” Stat said and cited by FirecePharma.com.
The drug has an annual price of $ 56,000, according to Bloomberg News.
In the statement on the layoffs, the spokesperson explained:
“Biogen is making changes to its patient services organization in Raleigh, NC to reallocate resources due to the delay in accessing patients from Aduhelm and the continued efficiency gains achieved through new technologies.
Affected employees will receive severance pay and transition services, the company noted.
“Biogen continues to invest in our patient service capabilities to help patients and healthcare providers deliver a high quality patient and customer experience,” the spokesperson explained.